MaRS Centre, South Tower 200-101 College St, Toronto, ON

Ambit discovers and develops novel drugs aimed at important diseases in the areas of stroke and other CNS disorders, cancer, and inflammation. Our lead drug candidates include neuroprotectants for treatment of stroke and other CNS disorders and kinase ...